The Centers for Medicare & Medicaid Services has revised the way Medicare administrative contractors make local coverage determinations for medical technologies, as required by the 21st Century Cures Act to promote transparency. Among other changes, the updated process expands who can participate on the contractor advisory committees that inform LCDs, opens CAC meetings to the public and requires a standardized summary of the clinical evidence supporting an LCD decision. CMS said the changes, published as an update to the Medicare Program Integrity Manual, will clarify and simplify the LCD process so that companies can get therapies and devices to patients more efficiently.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Perspective
Public
Staff Sgt. Ronald Shurer was awarded the Medal of Honor for his actions in Afghanistan in 2008 when he repeatedly exposed himself to enemy fire to treat…
Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
The AHA has released a social media toolkit with sample posts and graphics encouraging people to sign up for 2026 health coverage via the Health Insurance…
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
A new report from KFF reveals that Medicare Advantage enrollees had access to just 48% of the physicians available to Traditional Medicare beneficiaries in…